Published in Oncogenesis on June 12, 2017
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest (2002) 21.08
Hepatocellular carcinoma. N Engl J Med (2011) 19.40
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer (2007) 10.20
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics (2009) 8.60
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab (2008) 6.60
Cellular fatty acid metabolism and cancer. Cell Metab (2013) 2.82
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology (2010) 2.48
CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation. Cell Cycle (2010) 2.26
Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem Soc Trans (2002) 1.82
A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene (1997) 1.57
Connecting mTORC1 signaling to SREBP-1 activation. Curr Opin Lipidol (2012) 1.32
Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol (2008) 1.25
TIP30 deficiency increases susceptibility to tumorigenesis. Cancer Res (2003) 1.20
microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions. Oncogene (2013) 1.18
TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression. Hum Pathol (2006) 1.16
Decreased TIP30 expression promotes tumor metastasis in lung cancer. Am J Pathol (2009) 1.16
TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma. Cancer Res (2008) 1.15
Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des (2014) 1.11
SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma. Int J Mol Sci (2014) 1.10
Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Clin Cancer Res (2008) 1.09
Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma. Hepatology (2008) 1.09
Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro. Oncogene (2001) 1.04
TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Hepatology (2006) 1.03
The mTOR pathway in hepatic malignancies. Hepatology (2013) 1.02
Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells. J Biol Chem (2011) 1.01
HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Clin Cancer Res (2013) 1.00
A novel TIP30 protein complex regulates EGF receptor signaling and endocytic degradation. J Biol Chem (2011) 0.98
Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Ann Surg Oncol (2013) 0.98
TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice. Oncogene (2012) 0.95
CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness. J Biol Chem (2013) 0.95
The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer (2016) 0.95
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study. Hepatology (2016) 0.93
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans. J Hepatol (2015) 0.93
Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors. Cancer Res (2010) 0.92
Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma. Oncogene (2014) 0.92
TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma. Oncotarget (2015) 0.91
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice. Sci Rep (2016) 0.90
CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways. J Hepatol (2015) 0.89
Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients. Int J Cancer (2013) 0.87
Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma. J Surg Res (2013) 0.87
TIP30 is associated with progression and metastasis of prostate cancer. Int J Cancer (2008) 0.86
TIP30 regulates apoptosis-related genes in its apoptotic signal transduction pathway. World J Gastroenterol (2005) 0.86
Contribution of TIP30 to chemoresistance in laryngeal carcinoma. Cell Death Dis (2014) 0.80
Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol (2017) 0.79
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells. Liver Int (2016) 0.78
Advanced Hepatocellular Cancer: the Current State of Future Research. Curr Treat Options Oncol (2016) 0.78
High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker. Eur J Med Res (2013) 0.77
TIP30: A Novel Tumor-Suppressor Gene. Oncol Res (2015) 0.77
Overexpression of TIP30 inhibits the growth and invasion of glioma cells. Mol Med Rep (2015) 0.77
Proteomic analysis of livers from fat-fed mice deficient in either PKCδ or PKCε identifies Htatip2 as a regulator of lipid metabolism. Proteomics (2014) 0.76
Inhibition of the SREBP pathway suppresses hepatocellular carcinoma through repressing inflammation. Hepatology (2016) 0.76